Medical marijuana, compassionate use, and public policy: Expert opinion or vox populi?

Hastings Center Report

Volumn 36, Issue 3, 2006, Pages 19-22

  Cohen, Peter J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

CANNABIS SMOKING; CONSENSUS DEVELOPMENT; DRUG CONTROL; DRUG LEGISLATION; EMPATHY; FOOD AND DRUG ADMINISTRATION; HERBAL MEDICINE; HUMAN; LEGAL ASPECT; POLICY; REVIEW; UNITED STATES;

CALIFORNIA; CANNABIS; CONSENSUS DEVELOPMENT CONFERENCES, NIH; DRUG AND NARCOTIC CONTROL; EMPATHY; HUMANS; LEGISLATION, DRUG; MARIJUANA SMOKING; MEDICINE, HERBAL; PUBLIC POLICY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33745890906     PISSN: 00930334     EISSN: None     Source Type: Journal    
DOI: 10.1353/hcr.2006.0037     Document Type: Review

References (16)

1. C.E. Schneider, "A Government of Limited Powers," Hastings Center Report 35, no. 4 (2005): 11-12.
2. Ashcroft v. Raich, 124 S. Ct. 2909 (2004). "Medical marijuana" refers to any form of Cannabis saliva used to treat a wide variety of pathologic states and diseases. Its adherents claim (with pharmacologic justification) that smoking allows easy titration and rapid onset of its pharmacologic effects.
3. Section 505(d) of the Federal Food, Drug, and Cosmetic Act, United States Code, Title 21, as amended, sec. 321 et. seq. (2000).
4. See P.J. Cohen, "Science, Politics, and the Regulation of Dietary Supplements: It's Time to Repeal DSHEA," American Journal of Law & Medicine 31, nos. 2 and 3 (2005): 175-214.
5. See United States v. Oakland Cannabis Buyers Cooperative, 121 S. Ct. 1711 (2001).
6. E. Nieves, "User of Medical Marijuana Says She'll Continue to Fight," The Washington Post, June 7, 2005.
7. M.W. Grey, "Medical Use of Marijuana: Legal and Ethical Conflicts in the Patient/Physician Relationship," University of Richmond Law Review 30, no. 1 (1996): 249-74.
8. Food, Drug, and Cosmetic Act, United States Code, Title 21, as amended, sec. 201(g)(1)(B) and (C).
9. J.H. Jaffe and W.R. Martin, "Opioid Analgesics and Antagonists," in The Pharmacological Basis of Therapeutics, ed. A.C. Gilman, L.S. Goodman, and A. Gilman (New York: Macmillan, 1980), 494-534: Paregoric, U.S.P. (camphorated opium tincture) is a hydroalcoholic preparation in which there is also benzole acid, camphor, and anise oil. The usual adult dose is 5 to 10 ml, which corresponds to 2 to 4 mg of morphine.
10. Physicians' Desk Reference (Montvale, N.J.: Thompson PDR, 2005), 2816.
11. National Institutes of Health, "Workshop on the Medical Utility of Marijuana," February 19-20, 1997, Executive Summary; available at http://www.nih.gov/news/medmarijuana/MedicalMarijuana.htm, p. 2.
12. "Workshop on the Medical Utility of Marijuana," February 19-20, 1997, Executive Summary. Ibid., 4.
13. "Workshop on the Medical Utility of Marijuana," February 19-20, 1997, Executive Summary. Ibid., 4.
14. Section 505(d) of the Federal Food, Drug, and Cosmetic Act.
15. P.J. Cohen, "The Politics of Marijuana," in Drugs, Addiction, and the Law: Policy, Politics, and Public Health (Durham, N.C.: Carolina Academic Press, 2004), 290-92.
16. United States v. Rutherford, 442 U.S. 544, 558 (1979).